|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From Divisions of Neurology (D.M.A., D.Z., S.S., R.A.W.) and Neurosurgery (C.H., M.H., A.M.L.), Krembil Neuroscience Centre, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada.
* To whom correspondence should be addressed. E-mail: r.wennberg{at}utoronto.ca.
Abstract-- The authors describe long-term follow-up (mean, 5 years) in patients with anterior (AN) (n = 6) or centromedian (n = 2) thalamic deep brain stimulation (DBS) for epilepsy. Five patients (all AN) had
50% seizure reduction, although benefit was delayed in two until years 5 to 6, after changes in antiepileptic drugs. DBS electrode implantation in AN patients was followed by seizure reduction 1 to 3 months before active stimulation, raising the possibility of a beneficial microthalamotomy effect.
This article has been cited by other articles:
![]() |
R. P. Lesser and W. H. Theodore If not pharmacology, maybe physics Neurology, May 23, 2006; 66(10): 1468 - 1469. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |